No Data
No Data
Spot information for individual stocks (1)
Astellas Pharma <4503.T> continues to rise. The core operating profit Financial Estimates for the fiscal year ending March 2026 (consolidated) is expected to be 410 billion yen (a 5% increase from the previous year). Anritsu <6754.T> surges sharply. The consolidated operating profit Financial Estimates for the fiscal year ending March 2026 is expected to be 15 billion yen (a 24% increase from the previous year). AGP <9377.T> hits the upper limit in a buying trend. JAL <9201.T> proposed a stock merger as part of its privatization plan. Fujitsu <6755.T> (under supervision) remains steady. A TOB (public stock purchase) by Paloma Reem Holdings is underway.
Stocks that moved and those that were traded in the front market.
*Toyota Industries Corporation <6201> 16225 - reports suggest consideration for privatization of stocks. *Aichi Steel Corporation <5482> 8840 +1200 recognized for last period's double-digit profit increase and significant dividend increase plan this period. *Kinden Corporation <1944> 3838 +417 this period's guidance exceeds consensus. *Mitsui E&S Holdings <7003> 1857 +199 reports indicate the Trump administration's request for Japan for dual-use shipbuilding, regarded as a buying opportunity. *Anritsu Corporation <6754> 1401.5 +122 exceeds expectations.
Kinden, Yamazaki Pan ETC (additional) Rating
Downgrade - Bearish Code Stock Name Securities Company Previous After--------------------------------------------------------------<6523> PHCHD Morgan Stanley "Equal Weight" "Under Weight" <8591> ORIX Morgan Stanley "Over Weight" "Equal Weight" Target Price Change Code Stock Name Securities Company Previous After------------------------------------
Anritsu surged, expecting significant profit increase for the fiscal year ending March 2026.
Anritsu <6754.T> has surged sharply, temporarily rising 136.5 yen to 1,416 yen. After the market closed on the previous weekend on the 25th, it announced the consolidated financial estimates for the fiscal year ending March 2026. It showed a significant increase in operating profit, attracting STAR. For the fiscal year ending March 2026, the estimates are sales revenue of 123 billion yen (up 8.9% from the previous year) and operating profit of 15 billion yen (up 23.7% from the previous year). In the PQA (Products Quality Assurance) business, the introduction of new products is being accelerated, and the automation and reduction of personnel in the quality assurance processes of the food market are being pursued.
The Nikkei average is up about 180 yen, but after the buying spree, it seems to be facing resistance at higher levels = session before noon on the 28th.
On the 28th at around 10:02 AM, the Nikkei Stock Average was trading around 35,890 yen, up about 180 yen compared to the previous weekend. At 9:34 AM, it reached 36,075 yen and 26 sen, up 369 yen and 52 sen, marking the first time in about a month that it has recovered to the 36,000 yen range during trading hours since the first of the month. On the local market on the 25th, U.S. markets saw gains in technology stocks, with the NY Dow and the Nasdaq Composite Index both rising for four consecutive days. Japanese stocks also saw early buying thanks to the rise in U.S. stocks and stability in the foreign exchange market. However, Buy
April 28th [Today's Investment Strategy]
[Fisco Selected Stocks]【Material Stocks】Hokkan Holdings <5902> 1,699 yen (4/25) Engaged in food cans, PET bottles, and filling business. The profit forecast for the fiscal year ending March 2025 has been revised upward. The estimated operating profit is 4.5 billion yen (up 2.5% from the previous year). This is an upward revision of about 9% from the previous financial estimates, resulting in a projected increase in profit. Revenue is expected to be lower than the previous forecast, but due to cost reductions in factory expenses and Logistics costs, profit has been upwardly revised. The year-end Dividends have been set at 70 yen.